Equities
Health CareMedical Equipment and Services
  • Price (JPY)2,538.00
  • Today's Change-36.50 / -1.42%
  • Shares traded2.40m
  • 1 Year change+29.00%
  • Beta1.1742
Data delayed at least 20 minutes, as of Apr 19 2024 06:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.

  • Revenue in JPY (TTM)885.17bn
  • Net income in JPY99.04bn
  • Incorporated1921
  • Employees30.21k
  • Location
    Terumo Corp2-44-1, HatagayaSHIBUYA-KU 151-0072JapanJPN
  • Phone+81 333748111
  • Fax+81 333748399
  • Websitehttps://www.terumo.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fisher & Paykel Healthcare Corporatn Ltd154.65bn23.89bn1.43tn6.56k59.718.8843.009.230.44850.44852.903.020.75561.807.85258,104.8011.6719.5313.6723.7059.6963.2715.4521.771.2994.240.155846.94-5.9810.02-33.595.6516.4413.77
Cochlear Ltd213.43bn34.79bn2.07tn4.80k59.8011.6947.689.705.325.3232.6427.230.86021.745.14447,791.7014.028.9117.4511.6975.4674.9716.3012.191.94175.390.10490.6317.467.263.983.5814.051.92
Shanghai United Img Hlthcare Co Ltd230.98bn38.92bn2.15tn7.30k55.305.60--9.322.212.2113.1221.830.46581.424.661,480,689.007.91--10.17--49.37--16.98--2.76--0.0234--27.36--16.86------
Olympus Corp916.09bn39.47bn2.68tn32.84k69.253.4825.902.9231.83215.71741.15633.640.64051.695.4227,892,220.002.796.683.759.5367.0865.334.359.791.5812.010.288919.9717.572.3224.8319.282.1817.98
Terumo Corp885.17bn99.04bn3.87tn30.21k39.053.1722.384.3766.5066.50594.27818.280.54721.695.3329,303,340.006.126.437.377.5151.4853.0011.1912.471.13--0.156928.2416.626.890.5765-0.435311.809.86
FUJIFILM Holdings Corp2.92tn239.28bn4.29tn73.88k17.371.4011.241.47198.70198.702,424.912,467.830.67152.874.8739,527,220.005.444.957.156.4840.1040.518.107.260.9053--0.1723.7813.193.283.859.2831.7211.63
Hoya Corp751.55bn166.84bn6.19tn36.57k37.347.0128.638.23471.99471.992,126.342,512.990.71390.95265.5520,550,520.0015.9216.3518.4819.0985.8984.8122.3022.654.11--0.028826.029.396.202.3611.1313.247.96
Data as of Apr 19 2024. Currency figures normalised to Terumo Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

30.60%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 30 Sep 2023122.48m8.22%
Nikko Asset Management Co., Ltd.as of 05 Apr 202455.61m3.73%
Daiwa Asset Management Co. Ltd.as of 29 Mar 202454.06m3.63%
The Vanguard Group, Inc.as of 05 Apr 202452.56m3.53%
Asset Management One Co., Ltd.as of 14 Apr 202343.13m2.89%
Mitsubishi UFJ Asset Management Co., Ltd.as of 09 Oct 202330.98m2.08%
BlackRock Fund Advisorsas of 04 Apr 202425.83m1.73%
Schroder Investment Management Ltd.as of 27 Mar 202425.13m1.69%
Norges Bank Investment Managementas of 31 Dec 202325.00m1.68%
National Mutual Insurance Fed. of Agricultural Cooperativesas of 30 Sep 202321.31m1.43%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.